Paying prices we can ill afford

Medicines for Ireland claims policies on biosimilar products prevent taxpayers from gaining €25 million in savings on vital medicines

12th August, 2018

In a recent examination of hospital costs, the Department of Public Expenditure highlighted a €115 million increase in spending on medicines between 2014 and 2017.

Public hospitals spent €451 million on medicines in 2017 – up from €336 million in 2014.

Hospital expenditure only represents a fraction of the HSE’s total bill on medicines, as the bulk of expenditure emanates from medicines that are dispensed from pharmacies under various state drug schemes.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Susan O’Keeffe: Missed cancer diagnoses hint at true toll of fight against Covid-19

De Gascun: negative result not passport to ignore advice

Health Aaron Rogan 2 days ago

HSE spent €740,000 refurbishing headquarters over past three years

Health Claire McNamara 5 days ago

Resurgence in Covid-19 halted as new cases decline again

Health Rachel Lavin 6 days ago